Contact Us

T: 0044 2082020871 

T: 009723 6421886 

E: lihongfen@gmail.com

UK Address

1 Aviation Drive, Beaufort Park, London,

NW9 5TZ

Адрес

Улица Барзель 3, Тель-Авив

כתובת

הברזל 3 תל אביב

Dr. Li Hong Fen – Professor of Chinese medicine combined with Western medicine and medical plants
Patents

Dr Li has two major patents. Anti-Cancer Number One (ACNO), Composition for Treatment of Malignant Tumors, ACNO has been used for 30 years in China and more than 20 years in Israel. Thousands of cancer patients have been  treated. The efficacy of ACNO used singularly was 69.7% and combined with western medicine (electro-chemical therapy) was 84.3%. Research has shown that ACNO increased natural killer cells activity and inhibited metastasis of tumors. (Ref.: International Immunopharmacology, 2001, 1:1947-1956). 


Dr Li’s patent for the treatment of bronchial asthma, Ping Chuang Chong Ji, is a tonic made with anti-asthma herbs. It has been used for 30 years in China and almost 20 years in Israel. Thousands of patients have been treated. The effective rate is 90%. The drug can improve pulmonary function, blood partial pressure, increase CD2, CD4, CD4/CD8, and reduce IgE in blood.


Dr Li’s team has now finished the clinical research to treat asthma patients with Ping Chuan Chong Ji in the Pulmonary Institute of Chaim Sheba Medical Center, Tel-Hashomer Hospital, and the results are soon to be  published.

The International Chinese Medicine Cancer Research Center has established the following program objectives.

  • Identify Chinese Herbs which have anticancer effect and directly kill the cancer cells.

  • Perform basic animal research studies including inhibiting the cancer cells, change the cancer cells to normal and mechanism of enhancing the immune system, such as NK cells, T cells and CAMP/CGMP, change the cancer cells to normal, P53,WT etc. (5-8 years).

  • Carry out clinical research on cancer patients using Chinese Medicine for up to 20 years.

  • Initiate large-scale treatment trail in the medical centers of China and  Israel.

  • Ultimately expand the center to involve the United States, Europe and China themselves  .